Vectormune HVT-AIV

Authorised

This medicine is authorised for use in the European Union

Avian influenza vaccine

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  Vectormune HVT-AIV
• Active substance:
  turkey herpesvirus, strain rHVT/AI-H5 (cell-associated), expressing haemagglutinin gene of Avian influenza subtype H5, live
• International non-proprietary name (INN) or common name:
  Avian influenza vaccine

Pharmacotherapeutic group

• Immunologicals for aves
• Live viral vaccines
• Domestic fowl

Authorisation details

• EMA product number:
  EMEA/V/C/006288

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Vectormune HVT-AIV

Adopted Reference Number: EMA/CVMP/28067/2025